Skip to content
request access

the Circle. · BILS 2027 · Berlin

The infrastructure that carries biology to scale.

10-11 February 2027 · Hotel Palace Berlin · Invited Audience
the Why
What scales.  ·  What purifies.  ·  Who manufactures the future.

01

Every biologics leader faces the same question. How does discovery become medicine at scale. The infrastructure between candidate and patient is being rebuilt.

02

Closed-door. By invitation. End-user led. A circle for the leaders building what comes next.

03

the Conversation. BILS is that room. Senior biologics leadership convened around the work that compounds. Upstream. Downstream. CDMO. Digital manufacturing and supply. Less noise. More signal.

04

Who attends. Senior faculty drawn from the leaders who own the plant, sign the batch and carry the accountability. Announced in cadence with the programme.

Thesis · The Room

Who manufactures
the future.

The gap.

Biology moves faster than the infrastructure designed to carry it. Process validation still needs a human signature. The recommendation behind it is now algorithmic. Viral safety clearance follows predictive models. Sterile filtration integrity is monitored by systems that outrun the operator. The compliance gap between model output and accountability has never been formally named.

The Conversation.

The corridor where biologics ambition becomes clinical supply · or breaks. The Conversation is where the leaders who carry the accountability meet before the inspection does.

The decision.

For the leaders who own the plant, sign the batch and are accountable for the intelligence layer no one has formally governed.

Uwe Gottschalk

Conference Chair · Operating Partner, Keensight Capital

The leaders.

Faculty announced in cadence with the programme.

the Circle. bils.ai · Invited to the Room

The room.

Up to

150

senior leaders

Ratio

80/20

end-user · partner

Format

Two days

closed-door

Seniority

70%+

named principals

By invitation. By relevance. By room.

BILS · The room. Over the years.

The forum, in frame.

Voices →
Jesse McCool · CEO · GBI Bio · BILS · on stage
BILS 2026 On stage.
Speaker on stage · BILS 2026 · the conversation
BILS 2026 The conversation.
Nuno Fontes · WuXi Biologics · BILS 2026 · panel · in the room
BILS 2026 In the room.
Judy Chou · President & CEO · AltruBio · BILS · on stage
BILS 2026 In the room.
Angela Vollstedt · Novartis · BILS · on stage
BILS 2026 For the patients.
Jesse McCool · CEO · GBI Bio
Judy Chou · President and CEO · AltruBio
Speaker interview · BILS 2026 · in the room
BILS 2026 The interview.
Delegates · BILS · Innovation Leaders Summit · the room
BILS 2026 The room.
Partners · Who attends.

The organisations.

BILS 2027 · Berlin.
Who attends.

Asahi Kasei Bioprocess Cytiva Hamilton GEA Uncountable GenScript emp Biotech Intertek Keensight Capital Ypso Facto SGS PendoTECH

the Circle. bils.ai · Partner Positions

By request.
By invitation.

Partner packages and investment are shared directly.
Enter your access code to continue.

No access code? Request the prospectus →

the circle. · access

BILS 2027 · Request Access

The room
is taking
shape.

The prospectus is not public. Shared directly with the organisations that belong in the room.

Contact · For the Conversation

The conversation.

Manager · Life Sciences

Herbert Ryan

Life Sciences · BILS

Co-Producer & Operations

Sheryll Lusk

Operations · the circle.